KEAP1/NFE2L2 Pathway Signature Outperforms KEAP1/NFE2L2 Mutation Status and Reveals Alternative Pathway-Activating Mutations in NSCLC-Reference-Cited by-同舟云学术

KEAP1/NFE2L2 Pathway Signature Outperforms KEAP1/NFE2L2 Mutation Status and Reveals Alternative Pathway-Activating Mutations in NSCLC

Published:2023-07 Issue: Volume: Page:
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Arolt Christoph^ORCID,Dugan Margaret,Wild Robert,Richartz Vanessa,Holz Barbara,Scheel Andreas H.,Brägelmann Johannes,Wagener-Ryczek Svenja,Merkelbach-Bruse Sabine,Wolf Juergen,Buettner Reinhard,Catanzariti Luigi,Scheffler Matthias,Hillmer Axel M.

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference65 articles.

1. A genomics-based classification of human lung tumors;Sci Transl Med,2013

2. Implementation of amplicon parallel sequencing leads to improvement of diagnosis and therapy of lung cancer patients;König;J Thorac Oncol,2015

3. Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy;Skoulidis;Nat Rev Cancer,2019

4. Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2;Kobayashi;Mol Cell Biol,2004

5. Role of KEAP1/NFE2L2 mutations in the chemotherapeutic response of patients with non-small cell lung cancer;Jeong;Clin Cancer Res,2020

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic review and meta-analysis on the transcriptomic signatures in alcohol use disorder;Molecular Psychiatry;2024-09-06

2. „Kelch-like ECH-associated protein 1“ (KEAP1);Trillium Krebsmedizin;2024-08-06

3. Biomarkers of NRF2 signalling: Current status and future challenges;Redox Biology;2024-06

4. Redox ^high phenotype mediated by KEAP1/STK11/SMARCA4/NRF2 mutations diminishes tissue-resident memory CD8+ T cells and attenuates the efficacy of immunotherapy in lung adenocarcinoma;OncoImmunology;2024-04-09

5. Genotype Versus Phenotype: Defining Predictive Biomarkers of Immunotherapy Response;Journal of Thoracic Oncology;2023-12